Skip to main content
Log in

Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The absorption of a theophylline solution containing 80–120 mg doses delivered to different sites in the gastro-intestinal tract has been determined in 3 male volunteers using a remote controlled drug release system (HF-capsule). There was no difference between the stomach, ileum and the colon in the amount of theophylline absorbed (AUC). The T1/2abs of theophylline absorbed via the colon was prolonged when compared with that entering via the upper gastro-intestinal tract. The results provide a rational basis for the further development of theophylline formulations and are indispensable for planned development and to account for variation in the bioavailability of retarded release drug preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hirtz J (1984) The absorption window: Fact or fiction? Pharmacy Internat 5 (7): pp 175–178

    Google Scholar 

  2. Schuster O, Hugemann B, Graul EH, Loew D (1984) Absorptionslokalisation von Furosemid durch Verwendung einer ferngesteuerten Arzneimittelkapsel unter Röntgen- und CT-Kontrolle. In: Graul EH, Loew D (eds) Pathophysiologie und Therapie des gestörten Natrium- und Wasserhaushaltes, (Workshop Diuretika '84, Bad Nauheim April 1984), Medicef 1984, pp 128–137

  3. Caldwell J, Staib AH, Cotgreave IA, Siebert-Weigel M (1986) Intraindividual comparison of theophylline pharmacokinetics in human volunteers after intravenous infusion with ethylenediamine or sodium glycinate. Br J Clin Pharmacol 22: (in press)

  4. Jusko WJ, Polisczcuk A (1976) High-pressure liquid chromatographic and spectrophotometric assays for theophylline in biological fluids. Am J Hosp Pharm 33: 1193–1196

    Google Scholar 

  5. Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, Illinois

    Google Scholar 

  6. Betzien G, Kaufmann B, Schneider B, Ritschel WA (1985) KINPAK — a new program package for standardized evaluation of kinetic parameters. Arzneimittelforsch 35 [I] 1: 14–20

    Google Scholar 

  7. Hendeles L, Weinberger M, Johnson G (1980) Theophylline. In: Evans WE, Schentag JJ, Jusko WI (eds) Applied pharmacokinetics. Principles of therapeutic drug monitoring. Applied therapeutics, Inc. San Francisco 1980, chapter 6: pp 95–138

  8. Frömming KH, Schwabe L, Staib AH, Rietbrock N, Lassmann A, Molz KH, Schuppan D, Siebert-Weigel M, Voegele D (1983) Untersuchungen zur Liberation, Absorption und Elimination von Theophyllin bei rasch und verzögert freisetzenden oralen Arzneiformen. Arzneimittelforsch 33 [I] 3: 446–452

    Google Scholar 

  9. Schuppan D, Molz KH, Staib AH, Rietbrock N (1981) Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)-plasma levels after single and multiple oral doses. Int J Clin Pharmacol Ther Tox 19 [5]: 223–227

    Google Scholar 

  10. Bolme P, Edlund PO, Eriksson M, Paalzow L, Winbladh B (1979) Pharmacokinetics of theophylline in young children with asthma: Comparison of rectal enema and suppositories. Eur J Clin Pharmacol 16: 133–139

    Google Scholar 

  11. De Leede LGJ, De Boer AG, Van Vuelzen SL, Breimer DD (1982) Zero-order rectal delivery of theophylline in man with an osmotic system. J Pharmacokinet Biopharm 10 [5]: 525–537

    Google Scholar 

  12. Graul EH, Loew D, Schuster O (1985) Voraussetzung für die Entwicklung einer sinnvollen Retard- und Diuretikakombination — Untersuchungen von Furosemid in verschiedenen Darmabschnitten. Therapiewoche 35: 4277–4291

    Google Scholar 

  13. Schuster O, Haertel M, Hugemann B, Gikalov I, Schiemann O, Fenner H (1985) Untersuchungen zur klinischen Pharmakokinetik von Allopurinol, I. Mitt.: Allopurinol — Absorptionsorte und Dosisproportionalität der Allopurinol/Oxipurinol-Bioverfügbarkeit. Arzneimittelforsch 35 [I] 4: 760–765

    Google Scholar 

  14. Staib AH, Loew D, Harder S, Graul EH, Pfab R, Hugemann B (1985) Theophylline absorption at different gastrointestinal sites in the man: Studies employing a remote control liberation system (HF-capsule). Arch Pharmacol 330 [suppl] R 15 (abstr 66)

  15. Hugemann B, Schuster O (1982) Vorrichtung zur Freisetzung von Substanzen an definierten Orten des Verdauungstraktes. Patentschrift DE 2928477 C3 (A 61 K 9/00)

  16. Riegelman S, Collier P (1980) The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 8 [5]: 509–534

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

in technical collaboration with B. Hugemann, Frankfurt/Main

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staib, A.H., Loew, D., Harder, S. et al. Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device. Eur J Clin Pharmacol 30, 691–697 (1986). https://doi.org/10.1007/BF00608217

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00608217

Key words

Navigation